Concomitant bilateral papillary thyroid carcinoma and parathyroid adenoma
,
Abstract
Thyroid malignant neoplasms are the most prevalent cancer of the endocrine system, and their concurrence with parathyroid neoplasms is extremely rare. We report a 69-year-old woman presenting with hypercalcemia and thyroid nodule, which histologic examination revealed bilateral papillary thyroid carcinoma with different variants coincident with parathyroid adenoma. Awareness of concomitant parathyroid and thyroid diseases may help manage patients with hypercalcemia history. So, we recommended a preoperative calcium check in a patient with a thyroid nodule.
[1] Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents. Volume IX. IARC Scientific Publications. 2008; (160):1-837. [PMID]
[2] Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiology, Biomarkers & Preven- tion. 2009; 18(4):1092-100. [DOI:10.1158/1055-9965.EPI-08-0976] [PMID] [PMCID]
[3] Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. In- ternational patterns and trends in thyroid cancer incidence, 1973- 2002. Cancer Causes Control. 2009; 20(5):525-31. [DOI:10.1007/ s10552-008-9260-4] [PMID] [PMCID]
[4] Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiology, Biomarkers & Prevention. 2009; 18(3):784-91. [DOI:10.1158/1055-9965.EPI-08-0960] [PMID] [PMCID]
[5] Liu S, Semenciw R, Ugnat AM, Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: Time trends and age-period- cohort effects. British Journal of Cancer. 2001; 85(9):1335-9. [DOI:10.1054/bjoc.2001.2061] [PMID] [PMCID]
[6] Hajizadeh N, Pourhoseingholi M, Baghestani A. Incidence rate of thyroid cancer in Iranian population, trend analysis from 2003 to 2009. International Journal of Epidemiologic Research. 2015; 2(1):12-7. http://ijer.skums.ac.ir/article_10627.html
[7] Wu Y. The clinical application of central neck lymph nodes dissec- tion. J Surg Concepts Pract. 2003; 8:293. https://www.research- gate.net/publication/285977427_The_clinical_application_of_ central_neck_lymph_node_dissection
[8] Wang W, Gu J, Shang J, Wang K. Correlation analysis on central lymph node metastasis in 276 patients with cN0 papillary thyroid carcinoma. International Journal of Clinical and Experimental Pa- thology. 2013; 6(3):510-15. [PMID] [PMCID]
[9] Silverberg SJ, Bilezikian JP. Asymptomatic primary hyperparathy- roidism: A medical perspective. Surgical Clinics of North American. 2004; 84:787-801. [DOI:10.1016/j.suc.2004.03.002] [PMID]
[10] Morita SY, Somervell H, Umbricht CB, Dackiw AP, Zeiger MA. Evalu- ation for concomitant thyroid nodules and primary hyperparathy- roidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 2008; 144(6):862-6. [DOI:10.1016/j.surg.2008.07.029] [PMID]
[11] Kissin M, Bakst H. Co-existing myxedema and hyperparathy- roidism; Case report. The Journal of Clinical Endocrinology & Me- tabolism. 1947; 7(2):152-8. [DOI:10.1210/jcem-7-2-152] [PMID]
[12] Leitha T, Staudenherz A. Concomitant hyperparathyroidism and non-medullary thyroid cancer, with a review of the literature. Clinical Nuclear Medicin. 2003; 28(2):113-7. [DOI:10.1097/01. rlu.0000048680.30820.52] [PMID]
[13] Lee YS, Nam KH, Chung WY, Chang HS, Park CS. Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Journal of the Korean Surgical Society. 2011; 81:316-20. [DOI:10.4174/ jkss.2011.81.5.316] [PMID] [PMCID]
[14] Prinz RA, Barbato AL, Braithwaite SS, Brooks MH, Lawrence AM, Paloyan E. Prior irradiation and the development of coexistent dif- ferentiated thyroid cancer and hyperparathyroidism. Cancer. 1982; 49(5):874-7. [DOI:10.1002/1097-0142(19820301)49:5%3C874::aid- cncr2820490509%3E3.0.co;2-d] [PMID]
[15] Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Sch- neider AB. Multiple neoplasms in an irradiated cohort: Pattern of occurrence and relationship to thyroid cancer outcome. The Jour- nal of Clinical Endocrinology & Metabolism. 2002; 87(7):3236-41. [DOI:10.1210/jcem.87.7.8701] [PMID]
[16] LiVolsi VA, LoGerfo P, Feind CR. Coexistent parathyroid ad- enomas and thyroid carcinoma. Can radiation be blamed? Archives of Surgery. 1978; 113(3):285-6. [DOI:10.1001/arch- surg.1978.01370150057010] [PMID]
[17] Beebeejaun M, Chinnasamy E, Wilson P, Sharma A, Beharry N, Bano G. Papillary carcinoma of the thyroid in patients with primary hyperparathyroidism: Is there a link? Medical Hypotheses. 2017; 103:100-4. [DOI:10.1016/j.mehy.2017.04.016] [PMID]
[2] Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiology, Biomarkers & Preven- tion. 2009; 18(4):1092-100. [DOI:10.1158/1055-9965.EPI-08-0976] [PMID] [PMCID]
[3] Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. In- ternational patterns and trends in thyroid cancer incidence, 1973- 2002. Cancer Causes Control. 2009; 20(5):525-31. [DOI:10.1007/ s10552-008-9260-4] [PMID] [PMCID]
[4] Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiology, Biomarkers & Prevention. 2009; 18(3):784-91. [DOI:10.1158/1055-9965.EPI-08-0960] [PMID] [PMCID]
[5] Liu S, Semenciw R, Ugnat AM, Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: Time trends and age-period- cohort effects. British Journal of Cancer. 2001; 85(9):1335-9. [DOI:10.1054/bjoc.2001.2061] [PMID] [PMCID]
[6] Hajizadeh N, Pourhoseingholi M, Baghestani A. Incidence rate of thyroid cancer in Iranian population, trend analysis from 2003 to 2009. International Journal of Epidemiologic Research. 2015; 2(1):12-7. http://ijer.skums.ac.ir/article_10627.html
[7] Wu Y. The clinical application of central neck lymph nodes dissec- tion. J Surg Concepts Pract. 2003; 8:293. https://www.research- gate.net/publication/285977427_The_clinical_application_of_ central_neck_lymph_node_dissection
[8] Wang W, Gu J, Shang J, Wang K. Correlation analysis on central lymph node metastasis in 276 patients with cN0 papillary thyroid carcinoma. International Journal of Clinical and Experimental Pa- thology. 2013; 6(3):510-15. [PMID] [PMCID]
[9] Silverberg SJ, Bilezikian JP. Asymptomatic primary hyperparathy- roidism: A medical perspective. Surgical Clinics of North American. 2004; 84:787-801. [DOI:10.1016/j.suc.2004.03.002] [PMID]
[10] Morita SY, Somervell H, Umbricht CB, Dackiw AP, Zeiger MA. Evalu- ation for concomitant thyroid nodules and primary hyperparathy- roidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 2008; 144(6):862-6. [DOI:10.1016/j.surg.2008.07.029] [PMID]
[11] Kissin M, Bakst H. Co-existing myxedema and hyperparathy- roidism; Case report. The Journal of Clinical Endocrinology & Me- tabolism. 1947; 7(2):152-8. [DOI:10.1210/jcem-7-2-152] [PMID]
[12] Leitha T, Staudenherz A. Concomitant hyperparathyroidism and non-medullary thyroid cancer, with a review of the literature. Clinical Nuclear Medicin. 2003; 28(2):113-7. [DOI:10.1097/01. rlu.0000048680.30820.52] [PMID]
[13] Lee YS, Nam KH, Chung WY, Chang HS, Park CS. Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Journal of the Korean Surgical Society. 2011; 81:316-20. [DOI:10.4174/ jkss.2011.81.5.316] [PMID] [PMCID]
[14] Prinz RA, Barbato AL, Braithwaite SS, Brooks MH, Lawrence AM, Paloyan E. Prior irradiation and the development of coexistent dif- ferentiated thyroid cancer and hyperparathyroidism. Cancer. 1982; 49(5):874-7. [DOI:10.1002/1097-0142(19820301)49:5%3C874::aid- cncr2820490509%3E3.0.co;2-d] [PMID]
[15] Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Sch- neider AB. Multiple neoplasms in an irradiated cohort: Pattern of occurrence and relationship to thyroid cancer outcome. The Jour- nal of Clinical Endocrinology & Metabolism. 2002; 87(7):3236-41. [DOI:10.1210/jcem.87.7.8701] [PMID]
[16] LiVolsi VA, LoGerfo P, Feind CR. Coexistent parathyroid ad- enomas and thyroid carcinoma. Can radiation be blamed? Archives of Surgery. 1978; 113(3):285-6. [DOI:10.1001/arch- surg.1978.01370150057010] [PMID]
[17] Beebeejaun M, Chinnasamy E, Wilson P, Sharma A, Beharry N, Bano G. Papillary carcinoma of the thyroid in patients with primary hyperparathyroidism: Is there a link? Medical Hypotheses. 2017; 103:100-4. [DOI:10.1016/j.mehy.2017.04.016] [PMID]
| Files | ||
| Issue | Vol 7 No 1 (2022): January-February | |
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/crcp.v7i1.9631 | |
| Keywords | ||
| Thyroid carcinoma Parathyroid adenoma Coincident Surgery | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Hajebi R, Nazar E, Mashhadi S. Concomitant bilateral papillary thyroid carcinoma and parathyroid adenoma. CRCP. 2022;7(1):21-24.
